Abstract:BACKGROUND AND OBJECTIVES:Photodynamic therapy (PDT) has shown potentially beneficial results in treating port-wine stain, but its benefit-risk profile remains undefined. This study aimed to evaluate the efficacy and safety of PDT conducted with hemoporfin and a 532 nm continuous wave laser to treat port-wine stain clinically.PATIENTS AND METHODS:This randomized clinical trial was conducted in eight hospitals in China. Participants were adolescent and adult patients (age range: 14-65 years old) with port-wine stain. During stage 1 (day 1 to week 8) all patients were randomized at a 3:1 ratio to treatment (532 nm laser irradiation (96-120 J/cm2) with hemoporfin (5mg/kg; PDT-hemoporfin, n = 330)) or placebo groups (irradiation with placebo (PDT-placebo, n = 110)); during stage 2 (week 8 to 16) patients in both groups were offered treatment. Clinician-evaluators, who were blind to the study, classified each case on the following four-level scale according to assessment of before and after standardized pictures of the lesion area: no improvement: <20%; some improvement: 20-59%; great improvement: 60-89%; or nearly completely resolved: ≥90%. The primary efficacy endpoint was proportion of patients achieving at least some improvement at week 8. The secondary efficacy endpoints were proportion of patients achieving nearly completely resolved or at least great improvement at week 8, proportion of patients achieving early completely resolved, at least great improvement, or at least some improvement at week 16, and the corresponding satisfaction of the investigators and the patients (designated as 'excellent', 'good', 'moderate', or 'ineffective') at weeks 8 and 16.RESULTS:Compared to the PDT-placebo group, the PDT-hemoporfin group showed a significantly higher proportion of patients that achieved at least some improvement (89.7% [n = 295; 95% CI, 85.9%-92.5%] vs. 24.5% [n = 27; 95% CI, 17.4%-33.3%]) at week 8 (P < 0.0001) and higher improvements for all secondary efficacy endpoints. Treatment reactions occurred in 99.5% (n = 731; 95% CI, 98.7%-99.8%) of the PDT-hemoporfin treatments (n = 735). Hyperpigmentation occurred in 22.9 per 100 patient-treatments (n = 168; 95% CI, 20.0-26.0) in the PDT-hemoporfin treated patients.CONCLUSIONS:Hemoporfin-mediated PDT is an effective and safe treatment option for adolescent and adult patients with port-wine stain.TRIAL REGISTRATION:Chinese Clinical Trial Registry ChiCTR-TRC-08000213.

Hemoporfin-mediated photodynamic therapy on normal vasculature: implications for phototherapy of port-wine stain birthmarks.

Photodynamic Therapy in Treatment of Port Wine Stain Birthmarks—recent Progress

Recent progress in hematoporphyrin monomethyl ether-photodynamic therapy for port-wine stains: updates and insights

Advances in Photodynamic Therapy for Port-Wine Stain and Our Experience

Hemoporfin-Mediated Photodynamic Therapy for Port-Wine Stains on Extremities.

Efficacy and Safety of Hemoporfin in Photodynamic Therapy for Port-Wine Stain: A Multicenter and Open-Labeled Phase Iia Study

Hemoporfin-Mediated Photodynamic Therapy for Port-Wine Stains: Multivariate Analysis of Clinical Efficacy and Optical Coherence Tomography Appearance.

Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective study

Early history of clinical application of photosensitizing drugs in photodynamic therapy (PDT) of portwine stain (PWS) birthmarks

Retrospective Analysis of Hemoporfin-mediated Photodynamic Therapy in the Treatment of Naïve Port-Wine Stains

Hemoporfin Photodynamic Therapy for Port Wine Stain: A Randomized Controlled Trial

Evaluation of Efficacy of Hemoporfin-PDT in the Treatment of PWS Birthmarks of Young Children Previously Received PDL Treatment

Efficacy and influential factors of hematoporphyrin monomethyl ether mediated photodynamic therapy in the treatment for port-wine stains

Photodynamic Therapy of Port-Wine Stains: Long-Term Efficacy and Complication in Chinese Patients.

Comparison of Photodynamic Therapy and Pulsed Dye Laser in Patients with Port Wine Stain Birthmarks: A Retrospective Analysis

Comparison of Two Generation Photosensitizers of PsD-007 and Hematoporphyrin Monomethyl Ether Photodynamic Therapy for Treatment of Port-Wine Stain: A Retrospective Study.

Advances in the treatment of refractory port wine stains

Experimental study of combined photodynamic and photothermal therapy in the treatment of port wine stain

Photodynamic Therapy Using HMME for Port-Wine Stains: Clinical Effectiveness and Sonographic Appearance

Clinical Observation on the Therapeutic Effect of Port-Wine Stains with Intravenous Injection of Hematoporphyrin Monomethyl Ether (HMME)

Hemoporfin-mediated photodynamic therapy with general anesthesia showed superior efficacy in the treatment of port-wine stains: a retrospective evaluation